I’m not so concerned about timelines either. There are plenty of milestones coming up prior to FDA approval that should help increase value.
As a comparison look at EBR ($359m MC) & AVR ($331m MC) both have a significantly higher MC than EMV ($181m MC) yet they are still awaiting FDA approval. (Albeit both Class 3 devices).
- Forums
- ASX - By Stock
- EMV
- EMvision Research Notes
EMvision Research Notes, page-2617
-
-
- There are more pages in this discussion • 87 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add EMV (ASX) to my watchlist
(20min delay)
|
|||||
Last
$2.05 |
Change
0.065(3.27%) |
Mkt cap ! $175.3M |
Open | High | Low | Value | Volume |
$2.00 | $2.05 | $2.00 | $35.10K | 17.27K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 1206 | $2.00 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$2.05 | 5674 | 2 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 55 | 1.985 |
2 | 12371 | 1.950 |
1 | 2949 | 1.910 |
1 | 3300 | 1.905 |
3 | 9000 | 1.900 |
Price($) | Vol. | No. |
---|---|---|
2.050 | 5674 | 2 |
2.080 | 9000 | 1 |
2.150 | 227 | 1 |
2.160 | 918 | 1 |
2.170 | 4000 | 1 |
Last trade - 16.10pm 27/09/2024 (20 minute delay) ? |
Featured News
EMV (ASX) Chart |